Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

HDAC5 catalytic activity suppresses cardiomyocyte oxidative stress and NRF2 target gene expression
Tianjing Hu, Friederike Schreiter, Rushita A. Bagchi, et al.
Journal of Biological Chemistry (2019) Vol. 294, Iss. 21, pp. 8640-8652
Open Access | Times Cited: 38

Showing 1-25 of 38 citing articles:

The Roles of Histone Deacetylases and Their Inhibitors in Cancer Therapy
Li Guo, Yuan Tian, Wei‐Guo Zhu
Frontiers in Cell and Developmental Biology (2020) Vol. 8
Open Access | Times Cited: 269
HDAC inhibitors as pharmacological treatment for Duchenne muscular dystrophy: a discovery journey from bench to patients
Chiara Mozzetta, Vittorio Sartorelli, Prem Puri
Trends in Molecular Medicine (2024) Vol. 30, Iss. 3, pp. 278-294
Closed Access | Times Cited: 16
Nrf2 Activator PB125® as a Potential Therapeutic Agent against COVID-19
Joe M. McCord, Brooks M. Hybertson, Adela Cota‐Gomez, et al.
Antioxidants (2020) Vol. 9, Iss. 6, pp. 518-518
Open Access | Times Cited: 104
Host Serine Proteases: A Potential Targeted Therapy for COVID-19 and Influenza
Yalda Rahbar Saadat, Seyed Mahdi Hosseiniyan Khatibi, Sepideh Zununi Vahed, et al.
Frontiers in Molecular Biosciences (2021) Vol. 8
Open Access | Times Cited: 64
Epigenetic regulation of diverse regulated cell death modalities in cardiovascular disease: Insights into necroptosis, pyroptosis, ferroptosis, and cuproptosis
Cong Chen, Jie Wang, Shan Zhang, et al.
Redox Biology (2024) Vol. 76, pp. 103321-103321
Open Access | Times Cited: 9
Exercise, redox homeostasis and the epigenetic landscape
Ivan Dimauro, Maria Paola Paronetto, Daniela Caporossi
Redox Biology (2020) Vol. 35, pp. 101477-101477
Open Access | Times Cited: 54
HDAC9‐mediated calmodulin deacetylation induces memory impairment in Alzheimer's disease
Hailong Zhang, Shu‐Fen Hu, Pin Yang, et al.
CNS Neuroscience & Therapeutics (2024) Vol. 30, Iss. 2
Open Access | Times Cited: 8
Nanophytomedicines for the Prevention of Metabolic Syndrome: A Pharmacological and Biopharmaceutical Review
Zeinab Nouri, Marziyeh Hajialyani, Zhila Izadi, et al.
Frontiers in Bioengineering and Biotechnology (2020) Vol. 8
Open Access | Times Cited: 46
Zinc-dependent histone deacetylases: Potential therapeutic targets for arterial hypertension
Hae Jin Kee, Inkyeom Kim, Myung Ho Jeong
Biochemical Pharmacology (2022) Vol. 202, pp. 115111-115111
Open Access | Times Cited: 26
Expanding Role of Epigenetics in Human Health and Disease
Swarup K. Chakrabarti, Dhrubajyoti Chattopadhyay
Exploratory Research and Hypothesis in Medicine (2024) Vol. 000, Iss. 000, pp. 000-000
Open Access | Times Cited: 5
Histone deacetylases: potential therapeutic targets for idiopathic pulmonary fibrosis
Haipeng Cheng, Shi-he Jiang, Jin Cai, et al.
Frontiers in Cell and Developmental Biology (2024) Vol. 12
Open Access | Times Cited: 5
Nrf2 Activator PB125®as a Potential Therapeutic Agent Against COVID-19
Joe M. McCord, Brooks M. Hybertson, Adela Cota‐Gomez, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2020)
Open Access | Times Cited: 35
Redox signaling, mitochondrial metabolism, epigenetics and redox active phytochemicals
Renyi Wu, Shanyi Li, Rasika R. Hudlikar, et al.
Free Radical Biology and Medicine (2020) Vol. 179, pp. 328-336
Open Access | Times Cited: 35
Targeting epigenetic and post-translational modifications of NRF2: key regulatory factors in disease treatment
Xinyi Yang, Yingchao Liu, Jie Cao, et al.
Cell Death Discovery (2025) Vol. 11, Iss. 1
Open Access
Polyphenol‐Encapsulated Nanoparticles for the Treatment of Chronic Metabolic Diseases
Popat Mohite, Abhijeet Puri, Deepak Bharati, et al.
(2024), pp. 375-416
Closed Access | Times Cited: 3
HDAC5, an early osimertinib-responsive gene, is a novel therapeutic target for the drug resistance in EGFR-mutant lung adenocarcinoma cells
Hanbing Lyu, Akihiko Ishimura, Ryusuke Suzuki, et al.
Biochemistry and Biophysics Reports (2025) Vol. 42, pp. 102016-102016
Closed Access
Epigenetics/Epigenomics and Prevention of Early Stages of Cancer by Isothiocyanates
Rasika R. Hudlikar, Lujing Wang, Renyi Wu, et al.
Cancer Prevention Research (2020) Vol. 14, Iss. 2, pp. 151-164
Open Access | Times Cited: 27
Roles of Histone Acetylation Modifiers and Other Epigenetic Regulators in Vascular Calcification
Duk‐Hwa Kwon, Juhee Ryu, Young‐Kook Kim, et al.
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 9, pp. 3246-3246
Open Access | Times Cited: 22
Oxidative Stress-Induced Ferroptosis in Cardiovascular Diseases and Epigenetic Mechanisms
Jiamin Li, Yunxiang Zhou, Hui Wang, et al.
Frontiers in Cell and Developmental Biology (2021) Vol. 9
Open Access | Times Cited: 20
Moonlighting Metabolic Enzymes in Cancer: New Perspectives on the Redox Code
Jingwen Jiang, Liyuan Peng, Kui Wang, et al.
Antioxidants and Redox Signaling (2020) Vol. 34, Iss. 13, pp. 979-1003
Closed Access | Times Cited: 19
Chromatin modifiers in human disease: from functional roles to regulatory mechanisms
Yali Nie, Chao Song, Hong Huang, et al.
Molecular Biomedicine (2024) Vol. 5, Iss. 1
Open Access | Times Cited: 2
PROTAC‐Mediated HDAC7 Protein Degradation Unveils Its Deacetylase‐Independent Proinflammatory Function in Macrophages
Kailibinuer Kadier, Tian Niu, Baoli Ding, et al.
Advanced Science (2024)
Open Access | Times Cited: 2
Knockdown of histone deacetylase 9 attenuates sepsis-induced myocardial injury and inflammatory response
Yang Long, Chunxue Wu, Ying Cui, et al.
EXPERIMENTAL ANIMALS (2023) Vol. 72, Iss. 3, pp. 356-366
Open Access | Times Cited: 6
The Selective Class IIa Histone Deacetylase Inhibitor TMP195 Resensitizes ABCB1- and ABCG2-Overexpressing Multidrug-Resistant Cancer Cells to Cytotoxic Anticancer Drugs
Chung‐Pu Wu, Sabrina Lusvarghi, Jyun-Cheng Wang, et al.
International Journal of Molecular Sciences (2019) Vol. 21, Iss. 1, pp. 238-238
Open Access | Times Cited: 17
HDAC5 inhibition reduces angiotensin II-induced vascular contraction, hypertrophy, and oxidative stress in a mouse model
Liyan Bai, Hae Jin Kee, Sin Young Choi, et al.
Biomedicine & Pharmacotherapy (2020) Vol. 134, pp. 111162-111162
Open Access | Times Cited: 16
Page 1 - Next Page

Scroll to top